RELMADA THERAPEUTICS, INC. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate
RELMADA THERAPEUTICS, INC. (RLMD) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate of 98.00% for the 0-month period ending 2022-01-02, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate · last filed 2022-05-05
- 2022-01-02: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 0 month 98.00%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 0 month |
|---|---|
| 2022-01-02 | 98.00% 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |